Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Lupin secures EMA extended to label NaMuscla for children

Lupin Limited announced that the European Medicines Agency (EMA) has approved a change to the terms of marketing authorisation for NaMuscla, supported by the Pediatric Investigation Plan (PIP).

iStock
Emergency contraception availability is difficult beyond opening hours: Study

Emergency contraception is most effective when taken as soon as possible after unprotected sex or contraceptive failure.

gettyimages
Record high price concessions for fourth month; sector leaders worried

Company Chemists' Association chief executive Malcolm Harrison, CPE director of research and insights James Davies, and National Pharmacy Association chair Olivier Picard.

File photos